Current issues in measurement and reporting of urinary albumin excretion

Clinical Chemistry

Volumn 55, Issue 1, 2009, Pages 24-38

  Miller, W Greg ^a,m   Bruns, David E ^b   Hortin, Glen L ^c   Sandberg, Sverre ^d   Aakre, Kristin M ^d   McQueen, Matthew J ^e   Itoh, Yoshihisa ^f   Lieske, John C ^g   Seccombe, David W ^h   Jones, Graham ⁱ   Bunk, David M ^j   Curhan, Gary C ^k   Narva, Andrew S ^l  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e MCMASTER UNIVERSITY   (Canada)

^f ASAHIKAWA MEDICAL COLLEGE   (Japan)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l NATIONAL INSTITUTES OF HEALTH   (United States)

^m NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

CALIBRATION; CLINICAL CHEMISTRY; CLINICAL LABORATORY; HUMAN; LABORATORY TEST; PRACTICE GUIDELINE; PROTEIN STRUCTURE; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ALBUMINURIA; CHROMATOGRAPHY, LIQUID; COLORIMETRY; CREATININE; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY;

EID: 58149239885     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.106567     Document Type: Review

References (128)

1. Linksde Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 2006;17:2120-6.
2. American Diabetes Association Position Statement. Standards of medical care in diabetes. Diabetes Care 2007;30:S19-21.
3. International Diabetes Federation Clinical Guidelines Task Force. Global guidelines for type 2 diabetes; chapter 14: kidney damage. http://www.idf.org/ webdata/docs/GGT2D%2014 %20Kidney%20damade.pdf (Accessed November 2008).
4. Levey AS, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 2005;67:2089-100.
5. National Kidney Foundation. Kidney disease outcomes quality improvement (K/DOQI™) clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1-266.
6. National Kidney Foundation. Kidney disease outcomes quality improvement (K/DOQI™) clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49:S1-180.
7. Caring for Australians with Renal Injury (CARI) Guidelines. Urine protein as a diagnostic test. 2004. www.cari.org.au/ckd_urineprot_list_pub2004.php (Accessed November 2008).
8. Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners. Chronic kidney disease in adults: UK guidelines for identification, management and referral. London: Royal College of Physicians; 2006. 112 p.
9. Taal M, Tomson C. Clinical practice guidelines: module 1: chronic kidney disease. 2nd ed., final version. Petersfield (UK): The Renal Association; 2007. http://www.renal.org/guidelines/module1.html. (Accessed December 2008).
10. National Institute for Clinical Excellence. Management of type 2 diabetes: renal disease, prevention and early management (Guideline F); 2002. (Derived from the guideline entitled Diabetic Renal Disease: Prevention and Early Management commissioned from collaboration between the Royal College of General Practitioners, the Royal College of Physicians, and the Royal College of Nursing and Diabetes UK.) http://www.nice.org.uk/Guidance/F. (Accessed November 2008).
11. National Kidney Foundation. K/DOQI™ clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1-290.
12. Estivi P, Urbino R, Tetta C, Pagano G, Cavallo-Perin P. Urinary protein excretion induced by exercise: effect of a mountain agonistic footrace in healthy subjects: renal function and mountain footrace. J Sports Med Phys Fitness 1992;32:196-200.
13. Poortmans J, Dorchy H, Toussaint D. Urinary excretion of total proteins, albumin, and beta 2-microglobulin during rest and exercise in diabetic adolescents with and without retinopathy. Diabetes Care 1982;5:617-23.
14. Sentürk UK, Kuru O, Koçer G, Gündüz F. Biphasic pattern of exercise-induced proteinuria in sedentary and trained men. Nephron Physiol 2007;105:22-32.
15. Poortmans JR, Ouchinsky M. Glomerular filtration rate and albumin excretion after maximal exercise in aging sedentary and active men. J Gerontol A Biol Sci Med Sci 2006;61:1181-5.
16. Bertoluci MC, Friedman G, Schaan BD, Ribeiro JP, Schmid H. Intensity-related exercise albuminuria in insulin dependent diabetic patients. Diabetes Res Clin Pract 1993;19:217-25.
17. Huttunen NP, Käär ML, Pietiläinen M, Vierikko P, Reinilä M. Exercise-induced proteinuria in children and adolescents. Scand J Clin Lab Invest 1981;4:583-7.
18. Vittinghus E, Mogensen CE. Graded exercise and protein excretion in diabetic man and the effect of insulin treatment. Kidney Int 1982;21:725-9.
19. Robertshaw M, Cheung CK, Fairly I, Swaminathan R. Protein excretion after prolonged exercise. Ann Clin Biochem 1993;30 (Pt 1):34-7.
20. Clerico A, Giammattei C, Cecchini L, Lucchetti A, Cruschelli L, Penno G, et al. Exercise-induced proteinuria in well-trained athletes. Clin Chem 1990;36:562-4.
21. Garg SK, Chase HP, Shapiro H, Harris S, Osberg IM. Exercise versus overnight albumin excretion rates in subjects with type 1 diabetes. Diabetes Res Clin Pract 1995;28:51-5.
22. O'Brien SF, Watts GF, Powrie JK, Shaw KM. Exercise testing as a long-term predictor of the development of microalbuminuria in normoalbuminuric IDDM patients. Diabetes Care 1995;18:1602-5.
23. Hemmingsen, L, Skaarup P. Urinary excretion of ten plasma proteins in patients with febrile diseases. Acta Med Scand 1977;201:359-64.
24. Solling J, Solling K, Mogensen CE. Patterns of proteinuria and circulating immune complexes in febrile patients. Acta Med Scand 1982;212:167-9.
25. Richmond JM, Sibbald WJ, Linton AM, Linton AL. Patterns of urinary protein excretion in patients with sepsis. Nephron 1982;31:219-23.
26. Hernandez C, Simo R. Albumin excretion rate is not affected by asymptomatic urinary tract infection: a prospective study. Diabetes Care 2004;27:1565-9.
27. Carter JL, Tomson CR, Stevens PE, Lamb EJ. Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review. Nephrol Dial Transplant 2006;21:3031-7.
28. Watts GF, O'Brien SF, Shaw KM. Urinary infection and albumin excretion in insulin-dependent diabetes mellitus: implications for the measurement of microalbuminuria. Diabet Med 1996;13:520-4.
29. Dodge WF, West EF, Smith EH, Bruce Harvey 3rd. Proteinuria and hematuria in school-children: epidemiology and early natural history. J Pediatr 1976;88:327-47.
30. Vehaskari, VM, Rapola, J. Isolated proteinuria: analysis of a school-age population. J Pediatr 1982;101:661-8.
31. Wagner MG, Smith FG Jr, Tinglof BO Jr, Cornberg E. Epidemiology of proteinuria: a study of 4,807 schoolchildren. J Pediatr 1968;73:825-32.
32. Rytand DA, Spreiter S. Prognosis in postural (orthostatic) proteinuria: forty to fifty-year follow-up of six patients after diagnosis by Thomas Addis. N Engl J Med 1981;305:618-21.
33. Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR. Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med 1982;97:516-9.
34. Watts GF, Shaw KM, Polak A. The use of random urine samples to screen for microalbuminuria in the diabetic clinic. Practical Diabetes 1986;3:86-8.
35. Witte EC, Lambers Heerspink HJ, Bakker SJL, De Jong PE, De Zeeuw D, Gansevoort RT. Timed urine collections or spot urine samples to monitor albuminuria over time [Abstract]? J Am Soc Nephrol 2007;18:337A.
36. Hofmann W, Guder WG. A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989;27:589-600.
37. Mura-Galelli MJ, Voegel JC, Behr S, Bres EF, Schaaf P. Adsorption/desorption of human serum albumin on hydroxyapatite: a critical analysis of the Langmuir model. Proc Natl Acad Sci USA 1991;88:5557-61.
38. Hara F, Shiba K. Nonspecific binding of urinary albumin on preservation tube. Jpn J Clin Chem 2003;32(Suppl 1):28-9.
39. Nicholov R, Lum N, Veregin RPN, DiCosmo F. Human serum albumin adsorption at solid-liquid interface monitored by electron spin resonance spectroscopy. In: Horbett TA, Brash JL, eds. Proteins at interfaces II: fundamentals and applications. Washington (DC): American Chemical Society; 1995. p 280-95. (ACS symposium series, 0097-6165; 602).
40. Clark DC, Smith LJ, Wilson DR. A spectroscopic study of the conformational properties of foamed bovine serum albumin. J Colloid Interface Sci 1988;121:136-7.
41. Lad MD, Birembaut F, Matthew JM, Frazier RA, Green RJ. The adsorbed conformation of globular proteins at the air/water interface. Phys Chem Chem Phys 2006;8:2179-86.
42. Osberg I, Chase HP, Garg SK, DeAndrea A, Harris S, Hamilton R, Marshall G. Effects of storage time and temperature on measurement of small concentrations of albumin in urine. Clin Chem 1990;36:1428-30.
43. MacNeil MLW, Mueller PW, Caudill SP, Steinberg KK. Considerations when measuring urinary albumin: precision, substances that may interfere, and conditions for sample storage. Clin Chem 1991;37:2120-3.
44. Giampietro O, Penno G, Clerico A, Cruschelli L, Cecere M. How and how long to store urine samples before albumin radioimmunoassay: a practical response. Clin Chem 1993;39:533-6.
45. Tencer J, Thysell H, Andersson K, Grubb A. Long-term stability of albumin, protein HC, immunoglobulin G, Kappa- and lambda-chain-immunoreactivity, orosomucoid, and alpha 1-anti-trypsin in urine stored at -20 degrees C. Scand J Urol Nephrol 1997;31:67-71.
46. Brinkman JW, de Zeeuw D, Duker JJ, Gansevoort RT, Kema IP, Hillege HL, et al. Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. Clin Chem 2005;51:2181-3.
47. Sviridov D, Drake SK, Hortin GL. Reactivity of urinary albumin (microalbumin) assays with fragmented or modified albumin. Clin Chem 2008;54:61-8.
48. Brinkman JW, de Zeeuw D, Lambers Heerspink HJ, Gansevoort RT, Kema IP, De Jong PE, Bakker SJL. Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry. Clin Chem 2007;53:1520-6.
49. Hara F, Nakazato K, Shiba K. Studies of diabetic nephropathy; I, effects of storage time and temperature on microalbuminuria. Biol Pharma Bull 1994;17:1241-5.
50. Elving LD, Bakkeren JAJM, Jansen MJH, de Kat Angelino CM, de Nobel E, van Munster PJJ. Screening for microalbuminuria in patients with diabetes mellitus: frozen storage of urine decreases their albumin content. Clin Chem 1989;35:308-10.
51. Uemura Y. Preparation of reference material for albumin without lot difference. Laboratory Med 2004;5:557-61.
52. Harwell TS, McDowall JM, Eyler N, Little RR, Helgerson SD, Gohdes D. Laboratory testing for microalbuminuria in the general community. Diabetes Care 2000;23:1028-30.
53. Fagnani F, Souchet T, Labed D, Gaugris S, Hannedouche T, Grimaldi A. Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France-2001). Diabetes Metab 2003;29:58-64.
54. Edge JA, Swift PG, Anderson W, Turner B; Youth and Family Advisory Committee of Diabetes UK. Diabetes services in the UK: fourth national survey; are we meeting NSF standards and NICE guidelines? Arch Dis Child 2005;90:1005-9.
55. Aakre KM, Thue G, Subramaniam-Haavik S, Bukve T, Morris H, Müller M, et al. Postanalytical external quality assessment of urine albumin in primary health care: an international survey. Clin Chem 2008;54:1630-6.
56. Jones G. Urine albumin sampling and reporting: current practice in Australasia. Clin Biochem Newsl 2006:31-3.
57. Peters T. All about albumin: biochemistry, genetics, and medical applications. San Diego (CA): Academic Press; 1996. 432 pp.
58. Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY. Three-dimensional structure of human serum albumin. Science (Wash DC) 1989;244:1195-8.
59. Curry S, Mandelkow H, Brick P, Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nature (Lond) Struct Biol 1998;5:827-35.
60. Iwao Y, Hiraike M, Kragh-Hansen U, Mera K, Noguchi T, Anraku M, et al. Changes in net charge and alpha-helical content affect the pharmacokinetic properties of human serum albumin. Biochim Biophys Acta 2007;1774:1582-90.
61. Merler E, Remington JS, Finland M, Gitlin D. Differences between urinary albumin and serum albumin. Nature (Lond) 1962;196:1207-8.
62. Ghiggeri GM, Ginevri F, Candiano G, Oleggini R, Perfumo F, Queirolo C, Gusmano R. Characterization of cationic albumin in minimal change nephropathy. Kidney Int 1987;32:547-53.
63. Sudlow G, Birkett DJ, Wade DN. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 1976;12:1052-61.
64. Honoré B. Conformational changes in human serum albumin induced by ligand binding. Pharmacol Toxicol 1990;66 Suppl 2:7-26.
65. Kragh-Hansen U, Chuang VT, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 2002;25:695-704.
66. Ahmed-Ouameur A, Dianmantoglou S, Dedaghat-Herati MR, Nafishi SH, Carpentier R, Tajmir-Riahi HA. The effects of drug complexation on the stability and conformation of human serum albumin: protein unfolding. Cell Biochem Biophys 2006;45:203-13.
67. Fogh-Andersen N. Albumin/calcium association at different pH, as determined by potentiometry. Clin Chem 1977;23:2122-6.
68. Fogh-Andersen N, Bjerrum PJ, Siggaard-Andersen O. Ionic binding, net charge, and Donnan effect of human serum albumin as a function of pH. Clin Chem 1993;39:48-52.
69. Fujiwara S, Amisaki T. Molecular dynamics study of conformational changes in human serum albumin by finding of fatty acids. Proteins 2006;64:730-9.
70. Hortin GL, Meilinger B. Cross-reactivity of amino acids and other compounds in the biuret reaction: interference with urinary peptide measurements. Clin Chem 2005;51:1411-9.
71. Norden AGW, Sharratt P, Cutillas PR, Cramer R, Gardner SC, Unwin RJ. Quantitative amino acid and proteomic analysis: very low excretion of polypeptides >750 Da in normal urine. Kidney Int 2004;66:1994-2003.
72. Lowenthal MS, Mehta AL, Frogale K, Bandle RW, Araujo RP, Hood BL, et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 2005;51:1933-45.
73. Lopez MF, Mikulski A, Kuzdzal S, Golenko E, Petricoin EF 3rd, Liotta LA, et al. A novel, highthroughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clin Chem 2007;53:1067-74.
74. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993;39:263-71.
75. Hortin GL, Seam N, Hoehn GT. Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Clin Chem 2006;52:2258-64.
76. Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, et al. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol 2007;18:799-810.
77. Oettl K, Stauber RE. Physiological and pathological changes in the redox state of albumin critically influence its binding properties. Br J Pharmacol 2007;151:580-90.
78. Wiggins RC, Kshrisagar B, Kelsch RC, Wilson BS. Fragmentation and polymeric complexes of albumin in human urine. Clin Chim Acta 1985;149:155-63.
79. Ghiggeri GM, Candiano G, Delfino G, Queirolo C. Electrical charge of serum and urinary albumin in normal and diabetic humans. Kidney Int 1985;28:168-77.
80. Yagame M, Suzuki D, Jinde K, Yano N, Naka R, Abe Y, et al. Urinary albumin fragments as a new clinical parameter for the early detection of diabetic nephropathy. Intern Med 1995;34:463-8.
81. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P, et al. Repetitive fragmentation products of albumin and α1-antitrypsin in glomerular diseases associated with nephritic syndrome. J Am Soc Nephrol 2006;17:3139-48.
82. Sviridov D, Meilinger B, Drake SK, Hoehn GT, Hortin GL. Co-elution of other proteins with albumin during size-exclusion HPLC: implications for urine albumin analysis. Clin Chem 2006;52:389-97.
83. Chaudhury C, Mahnaz S, Robinson JM, Hayton WL, Pearl AM, Roopenian DC, Anderson CL. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 2003;197:315-22.
84. Westwood ME, Thornalley PJ. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins: comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J Protein Chem 1995;14:359 -72.
85. Wagner Z, Molnar M, Molnar GA, Tamasko M, Laczy B, Wagner L, et al. Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis 2006;47:294-300.
86. Cha T, Tahara Y, Yamato E, Yoneda H, Ikegami H, Noma Y, et al. Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy. Diabet Res Clin Pract 1991;12:149-56.
87. Cutillas PR, Chalkley RJ, Hansen KC, Cramer R, Norden AG, Waterfield MD, et al. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol 2004;287:F353-64.
88. Gekle M. Renal tubule albumin transport. Ann Rev Physiol 2005;67:573-94.
89. Hortin GL, Sviridov D. Analysis of molecular forms of albumin in urine. Proteomics Clin Appl 2008;2:950-5.
90. Thongboonkerd V, McLeish KR, Arthur JM, Klein JB. Proteomic analysis of normal urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int 2002;62:1461-9.
91. Lafitte D, Dussol B, Andersen S, Vazi A, Dupuy P, Jensen ON, et al. Optimized preparation of urine samples for two-dimensional electrophoresis and initial application to patient samples. Clin Biochem 2002;35:581-9.
92. Khan A, Packer NH. Simple urinary sample preparation for proteomic analysis. J Proteome Res 2006;5:2824-38.
93. Zerefos PG, Vougas K, Dimitraki P, Kossida S, Perolekas A, Stravodimos K, et al. Characterization of the human urine proteome by preparative electrophoresis in combination with 2-DE. Proteomics 2006;6:4346-55.
94. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 2007;18:913-22.
95. Kausler E, Spiteller G. Fragments from albumin and β2-microglobulin: constituents of the middle molecule fraction in hemofiltrate. Biol Chem Hoppe-Seyler 1991;372:849-55.
96. Heine G, Raida M, Forssmann WG. Mapping of peptides and protein fragments in human urine using liquid chromatography-mass spectrometry. J Chromatogr A 1997;776:117-24.
97. Raida M, Schulz-Knappe P, Heine G, Forssmann WG. Liquid chromatography and electrospray mass spectrometric mapping of peptides from human plasma filtrate. J Am Soc Mass Spectrom 1999;10:45-54.
98. Richter R, Schulz-Knappe P, Schrader M, Standker L, Jurgens M, Tammen H, Forssmann WG. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J. Chromatogr B 1999;726:25-35.
99. Wittke S, Mischak H, Walden M, Kolch W, Radler T, Wiedemann K. Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches. Electrophoresis 2005;26:1476-87.
100. Jurgens M, Appel A, Heine G, Neitz S, Menzel C, Tammen H, Zucht HD. Towards characterization of the human urinary peptidome. Comb Chem High Throughput Screen 2005;8:757-65.
101. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int 2005;67:2313-20.
102. Chalmers MJ, Mackay CL, Hendrickson CL, Wittke S, Walden M, Mischak H, et al. Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease. Anal Chem 2005;77:7163-71.
103. Kemperman RF, Horvatovich PL, Hoekman B, Reijmers TH, Muskiet FA, Bischoff R. Comparative urine analysis by liquid chromatographymass spectrometry and multivariate statistics: method development, evaluation, and application to proteinuria. J Proteome Res 2007;6:194-206.
104. Brenner BM, Hostetter TH, Humes HD. Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978;298:826-33.
105. Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, et al. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 2001;60:1885-92.
106. Brennan SO, George PM, Peach RJ. Characterisation of a slow component of normal human serum albumin. Clin Chim Acta 1988;176:179-84.
107. Brennan SO, George PM. Three truncated forms of serum albumin associated with pancreatic pseudocyst. Biochim Biophys Acta 2000;1481:337-43.
108. Bar-Or D, Rael LT, Bar-Or R, Slone DS, Craun ML. The formation and rapid clearance of a truncated albumin species in a critically ill patient. Clin Chim Acta 2006;365:346-9.
109. Vlaskou D, Hofmann W, Guder WG, Siskos PA, Dinyssiou-Asteriou A. Human neutral brush border endopeptidase EC 3.4.24.11 in urine, its isolation, characterization and activity in renal disease. Clin Chim Acta 2000;297:103-21.
110. Bond JS, Matters GL, Banerjee S, Dusheck RE. Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Lett 2005;579:3317-22.
111. Trof RJ, Di Maggio F, Leemreis J, Goeneveld AB. Biomarkers of acute renal injury and renal failure. Shock 2006;26:245-53.
112. Russo LM, Bakris GL, Comper WD. Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 2002;39:899-919.
113. Sakata S, Atassi MZ. Immunochemistry of serum albumin, X: five major antigenic sites of human serum albumin are extrapolated from bovine albumin and confirmed by synthetic peptides. Mol Immunol 1980;17:139-42.
114. Brinkman JW, Bakker SJ, Gansevoort RT, Hillege HL, Kema IP, Gans RO, et al. Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int 2004;66(92S):S69-75.
115. Giampietro O, Lucchetti A, Cruschelli L, Clerico A, Berni R, Penno G, et al. Measurement of urinary albumin excretion (UAE) in diabetic patients: immunonephelometry versus radioimmunoassay. J Nucl Med Allied Sci 1989;33:252-7.
116. Osicka TM, Comper WD. Characterization of immunochemically nonreactive urinary albumin. Clin Chem 2004;50:2286-91.
117. Clavant SP, Sastra SA, Osicka TM, Comper WD. The analysis and characterization of immunounreactive urinary albumin in healthy volunteers. Clin Biochem 2006;39:143-51.
118. Owen WE, Roberts WL. Performance characteristics of an HPLC assay for urinary albumin. Am J Clin Pathol 2005;124:219-25.
119. In vitro diagnostic medical devices - measurement of quantities in biological samples - metrological traceability of values assigned to calibrators and control materials. ISO 17511. Geneva: International Organization for Standardization; 2003.
120. Joint Committee for Traceability in Laboratory Medicine (JCTLM). Database of higher-order reference materials, measurement methods/procedures and services. http://www.bipm.org/jctlm/ (Accessed November 2008).
121. Baudner S, Bienvenu J, Blirup-Jensen S, Carlström A, Johnson AM, Ward AM, et al. The certification of a matrix reference material for immunochemical measurement of 14 human serum proteins. CRM470. BCR Publication 92/92. Brussels: BCR; 1992.
122. Reimer CB, Smith SJ, Wells TW, Nakamura RM, Keitges PW, Ritchie RF, et al. Collaborative calibration of the US National and the College of American Pathologists reference preparations for specific serum proteins. Am J Clin Pathol 1982;77:12-9.
123. Price CP, Newman DJ, Blirup-Jensen S, Gudar WG, Grubb A, Itoh Y, et al. First international reference preparation for individual proteins in urine. Clin Biochem 1998;31:467-74.
124. Itoh Y, Hosogaya S, Kishi K, Hiroko S. Standardization of immunoassays for urine albumin. Jpn J Clin Chem 2008;37:5-14.
125. Singh R, Crow FW, Babic N, Lutz WH, Lieske JC, Larson TS, Kumar R. A liquid chromatography-mass spectrometry method for the quantification of urinary albumin using a novel 15N-isotopically labeled albumin internal standard. Clin Chem 2007;53:540-2.
126. Babic N, Larson TS, Grebe SK, Turner ST, Kumar R, Singh RJ. Application of liquid chromatography -mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease. Clin Chem 2006;52:2155-7.
127. Gill SC, von Hippel PH. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 1989;182:319-26.
128. Siekmann L. Determination of creatinine in human serum by isotope dilution-mass spectrometry: definitive methods in clinical chemistry, IV. J Clin Chem Clin Biochem 1985;23:137-44.